Cutaneous vasculitis associated with fluoroquinolones
Authors:
- 7 August 2009
- journal article
- case report
- Published by Springer Nature in Infection
- Vol. 37 (5) , 466-468
Abstract
Cutaneous vasculitis is a clinical entity with a broad differential diagnosis, including an adverse drug reaction. It is defined as inflammation of skin blood vessel walls. During a 7-year-period, we observed three patients who developed isolated cutaneous vasculitis during antibiotic therapy of bacterial infection. All were treated with a fluoroquinolone (ciprofloxacin or levofloxacin) combined with rifampin (two cases) or flucloxacillin (three cases), respectively. In all three cases the lesions gradually resolved after treatment with the inciting fluoroquinolone had been stopped. In one patient, leukocytoclastic small-vessel vasculitis was histologically confirmed. Fluoroquinolone-associated cutaneous vasculitis consists of an isolated self-limiting disorder that is part of a systemic vasculitis, or even life-threatening disease. Clinicians should be aware of this serious adverse event because any continuation of treatment may be fatal.Keywords
This publication has 21 references indexed in Scilit:
- Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritisNephrology Dialysis Transplantation, 2005
- ABC of arterial and vascular disease: VasculitisBMJ, 2000
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Ofloxacin-Induced Hypersensitivity VasculitisThe American Journal of the Medical Sciences, 1996
- Drug-induced vasculitisCurrent Opinion in Rheumatology, 1996
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Cutaneous vasculitis due to ciprofloxacin.BMJ, 1992
- Fatal vasculitis associated with ofloxacin.BMJ, 1989
- Hypersensitivity vasculitis due to ofloxacin.BMJ, 1989